The invention relates to factor D inhibitors, which bind to factor D and block the functional activity of factor D in complement activation. The inhibitors include antibody molecules, as well as homologues, analogues and modified or derived forms thereof, including immunoglobulin fragments like Fab, F(ab)2 and Fv, small molecules, including peptides, oligonucleotides, peptidomimetics and organic compounds. A monoclonal antibody which bound to factor D and blocked its ability to activate complement was generated and designated 166-32. The hybridoma producing this antibody was deposited at the American Type Culture Collection, 10801 University Blvd., Manassas, Va. 20110-2209, under Accession Number HB-12476.


< Method for cloning and expression of AcuI restriction endonuclease and AcuI methylase in E. coli

< Sample plate for matrix-assisted laser desorption and ionization mass spectrometry

> Method for determining the presence or absence of respiring cells on a three-dimensional scaffold

> Plant-fiber containing composition for anaerobic bioremediation

~ 00215